Publicacións (11) Publicacións de José Luis Relova Quinteiro

filter_list Neurology

2022

  1. Concurrent Akt, ERK1/2 and AMPK Activation by Obestatin Inhibits Apoptotic Signaling Cascades on Nutrient-Deprived PC12 Cells

    Cellular and Molecular Neurobiology, Vol. 42, Núm. 5, pp. 1607-1614

  2. Parkinson’s Disease Symptoms Associated with Developing On-State Axial Symptoms Early after Subthalamic Deep Brain Stimulation

    Diagnostics, Vol. 12, Núm. 4

2021

  1. Continuous Subcutaneous Apomorphine Infusion before Subthalamic Deep Brain Stimulation: A Prospective, Comparative Study in 20 Patients

    Movement Disorders Clinical Practice, Vol. 8, Núm. 8, pp. 1216-1224

2019

  1. Continuous subcutaneous apomorphine in advanced Parkinson’s disease patients treated with deep brain stimulation

    Journal of Neurology, Vol. 266, Núm. 3, pp. 659-666

2018

  1. Improvement of Duchenne muscular dystrophy phenotype following obestatin treatment

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 9, Núm. 6, pp. 1063-1078

2017

  1. Delayed complications of deep brain stimulation: 16-year experience in 249 patients

    Acta Neurochirurgica, Vol. 159, Núm. 9, pp. 1713-1719

2016

  1. Bilateral pallidal deep brain stimulation in myoclonus-dystonia: our experience in three cases and their follow-up

    Acta Neurochirurgica, Vol. 158, Núm. 10, pp. 2023-2028

2013

  1. Recomendaciones para la utilización clínica del estudio de potenciales evocados motores en la esclerosis múltiple

    Neurologia, Vol. 28, Núm. 7, pp. 408-416

2012

  1. Growth hormone treatment enhances the functional recovery of sciatic nerves after transection and repair

    Muscle and Nerve, Vol. 45, Núm. 3, pp. 385-392

2011

  1. Estimulación cerebral en el tratamiento del dolor neuropático

    Revista española de investigaciones quirúrgicas, Vol. 14, Núm. 1, pp. 33-38

1992

  1. Fos expression in the trigeminal sensory nuclei after a chemical lesion of the lower lip mucosa

    NeuroReport, Vol. 3, Núm. 8, pp. 665-668